EXHIBIT 4.4

THESE SECURITIES HAVE NOT BEEN REGISTERED WITH THE UNITED STATES  SECURITIES AND
EXCHANGE  COMMISSION OR THE  SECURITIES  COMMISSION OF ANY STATE  PURSUANT TO AN
EXEMPTION FROM REGISTRATION  UNDER REGULATION D PROMULGATED UNDER THE SECURITIES
ACT OF 1933,  AS  AMENDED  (THE  "ACT") OR  OTHERWISE.  THIS  WARRANT  SHALL NOT
CONSTITUTE AN OFFER TO SELL NOR A SOLICITATION OF AN OFFER TO BUY THE SECURITIES
IN ANY JURISDICTION IN WHICH SUCH OFFER OR SOLICITATION  WOULD BE UNLAWFUL.  THE
SECURITIES  ARE  "RESTRICTED"  AND MAY NOT BE  RESOLD OR  TRANSFERRED  EXCEPT AS
PERMITTED UNDER THE ACT PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM.


                          COMMON STOCK PURCHASE WARRANT

No. [__]

              To Purchase Shares of $.03 Par Value Common Stock of

                               PHARMOS CORPORATION

     THIS  CERTIFIES   that,  for  value   received,   [________________]   (the
"Investor")  is  entitled,   upon  the  terms  and  subject  to  the  conditions
hereinafter  set forth,  at any time on or after the date hereof and on or prior
to 5:00 p.m. New York City Time on September 1, 2005 (the  "Termination  Date"),
but not thereafter,  to subscribe for and purchase from PHARMOS  CORPORATION,  a
Nevada  corporation  (the "Company"),  [________]  shares of Common Stock of the
Company (the  "Warrant  Shares").  The "Exercise  Price" is $6.08.  The Exercise
Price and the number of shares for which the  Warrant  is  exercisable  shall be
subject to  adjustment  as  provided  herein.  This  Warrant is being  issued in
connection  with the  [___________]  Agreement  dated  September  1,  2000  (the
"Agreement") entered into between the Company and the Investor.

1.   Title of Warrant.  Prior to the expiration hereof and subject to compliance
     with  applicable   laws,   this  Warrant  and  all  rights   hereunder  are
     transferable,  in whole or in respect of the right to purchase  any part of
     the  Warrant  Shares,  at the office or agency of the Company by the holder
     hereof in person or by duly  authorized  attorney,  upon  surrender of this
     Warrant  together  with (a) the  Assignment  Form annexed  hereto  properly
     endorsed,  and (b) any other documentation  reasonably necessary to satisfy
     the  Company  that  such  transfer  is in  compliance  with all  applicable
     securities laws.

2.   Authorization  of Shares.  The Company  covenants that all shares of Common
     Stock which may be issued upon the exercise of rights  represented  by this
     Warrant will,  upon exercise of the rights  represented by this Warrant and
     payment of the Exercise Price as set forth herein will be duly  authorized,
     validly issued, fully paid and nonassessable and free



     from all taxes,  liens and charges in respect of the issue  thereof  (other
     than taxes in respect of any transfer occurring contemporaneously with such
     issue or otherwise specified herein).

3.   Exercise of Warrant.

(a)  Exercise of the purchase rights  represented by this Warrant may be made at
     any time or times,  in whole or in part before the close of business on the
     Termination  Date, or such earlier date on which this Warrant may terminate
     as provided in paragraph 11 below,  by the surrender on any business day of
     this Warrant and the Notice of Exercise  annexed  hereto duly completed and
     executed,  at the principal  office of the Company (or such other office or
     agency of the  Company  as it may  designate  by notice in  writing  to the
     registered  holder  hereof at the address of such holder  appearing  on the
     books of the Company), together with delivery to the Company by such holder
     of all certifications or documentation  reasonably  necessary to establish,
     to the  satisfaction  of the  Company,  that  any  such  exercise  has been
     undertaken in compliance with all applicable  federal and state  securities
     laws,  and upon payment of the full  Exercise  Price of the shares  thereby
     purchased;  whereupon  the  holder of this  Warrant  shall be  entitled  to
     receive  a  certificate  for the  number  of  shares  of  Common  Stock  so
     purchased.  Certificates for shares purchased  hereunder shall be delivered
     to the holder  hereof within three (3) Trading Days after the date on which
     this  Warrant  shall  have been  exercised  as  aforesaid.  Payment  of the
     Exercise Price of the shares shall be by certified check or cashier's check
     or by wire  transfer  (of same day funds) to an account  designated  by the
     Company in an amount equal to the Exercise  Price  multiplied by the number
     of shares being purchased.

(b)  Alternatively,  and only in the event the Warrant Shares are not covered by
     an effective registration  statement,  the Warrant holder may exercise this
     Warrant,  in whole or in part in a "cashless"  or  "net-issue"  exercise by
     delivering  to the  offices of the  Company or any  transfer  agent for the
     Common Stock this Warrant,  together  with a Notice of Exercise  specifying
     the  number  of  Warrant  Shares to be  delivered  to such  Warrant  holder
     ("Deliverable  Shares")  and the number of Warrant  Shares with  respect to
     which  this  Warrant  is being  surrendered  in  payment  of the  aggregate
     Exercise Price for the Deliverable Shares ("Surrendered Shares").

     The number of Deliverable Shares shall be calculated as follows:


  
     # of Deliverable Shares = # of Surrendered Shares x Fair Market Value of Common Stock less Exercise Price
                                                         -----------------------------------------------------
                                                         Fair Market Value of Common Stock


     "Fair Market Value" shall have the meaning specified in Section 12(c)

     In the event  that the  Warrant  is not  exercised  in full,  the number of
     Warrant  Shares shall be reduced by the number of such  Warrant  Shares for
     which this Warrant is exercised and/or surrendered, and the Company, at its
     expense,  shall  within three (3) Trading Days issue and deliver to or upon
     the order of the Warrant  holder a new Warrant of like tenor


                                       2


     in the name of Warrant holder or as Warrant holder (upon payment by Warrant
     holder of any  applicable  transfer  taxes) may  request,  reflecting  such
     adjusted Warrant Shares.

     All  exercises  will be  deemed  to occur as of the date of the  Notice  of
     Exercise,  and certificates for shares of Common Stock purchased  hereunder
     shall be delivered to the holder hereof within three (3) Trading Days after
     the date on which this Warrant shall have been exercised as aforesaid.  The
     Warrant  holder may withdraw its Notice of Exercise  under  Section 3(a) or
     3(b) at any time  thereafter  if the  Company  fails to timely  deliver the
     applicable   certificates  to  the  Warrant  holder  as  provided  in  this
     Agreement.

(c)  In lieu of delivering physical  certificates  representing the Common Stock
     issuable  upon   exercise,   provided  the  Company's   transfer  agent  is
     participating  in the  Depository  Trust  Company  ("DTC")  Fast  Automated
     Securities  Transfer ("FAST") program,  upon request of the Warrant Holder,
     the  Company  shall use its best  efforts  to cause its  transfer  agent to
     electronically  transmit the Common  Stock  issuable  upon  exercise to the
     Warrant  Holder by crediting the account of Warrant  Holder's  prime broker
     with DTC through its Deposit  Withdrawal Agent Commission  ("DWAC") system.
     The time  periods  for  delivery  described  in the  immediately  preceding
     paragraph shall apply to the electronic transmittals described herein.

     The term  "Trading  Day" means (x) if the Common Stock is listed on the New
     York Stock Exchange or the American Stock Exchange, a day on which there is
     trading on such stock exchange, or (y) if the Common Stock is not listed on
     either of such stock  exchanges  but sale  prices of the  Common  Stock are
     reported  on an  automated  quotation  system,  a day on which  trading  is
     reported on the principal  automated quotation system on which sales of the
     Common  Stock  are  reported,  or  (z)  if  the  foregoing  provisions  are
     inapplicable,  a day on which quotations are reported by National Quotation
     Bureau Incorporated.

4.   No Fractional Shares or Scrip. No fractional  shares or scrip  representing
     fractional shares shall be issued upon the exercise of this Warrant.

5.   Charges, Taxes and Expenses.  Issuance of certificates for shares of Common
     Stock upon the exercise of this Warrant shall be made without charge to the
     holder hereof for any issue or transfer tax or other incidental  expense in
     respect  of the  issuance  of such  certificate,  all of  which  taxes  and
     expenses  shall  be paid by the  Company,  and such  certificates  shall be
     issued in the name of the  holder of this  Warrant or in such name or names
     as may be directed by the holder of this Warrant;  provided,  however, that
     in the event  certificates for shares of Common Stock are to be issued in a
     name other than the name of the holder of this  Warrant,  this Warrant when
     surrendered  for  exercise  shall be  accompanied  by the  Assignment  Form
     attached hereto duly executed by the holder hereof;  and provided  further,
     that the Company shall not be required to pay any tax or taxes which may be
     payable in respect of any transfer  involved in the issuance of any Warrant
     certificates  or any  certificates  for the Warrant  Shares  other than the
     issuance of a Warrant  Certificate  to the Investor in connection  with the
     Investor's  surrender  of a


                                       3


     Warrant  Certificate  upon the  exercise  of less than all of the  Warrants
     evidenced  thereby,  and the  Company  shall  not be  required  to issue or
     deliver such certificates  unless or until the person or persons requesting
     the issuance  thereof shall have paid to the Company the amount of such tax
     or shall have  established to the satisfaction of the Company that such tax
     has been paid.

6.   Closing of Books.  The Company will at no time close its shareholder  books
     or records in any manner which  interferes with the timely exercise of this
     Warrant.

7.   No Rights as  Shareholder  until  Exercise.  Subject  to Section 12 of this
     Warrant  and the  provisions  of any other  written  agreement  between the
     Company and the  Investor,  the  Investor  shall not be entitled to vote or
     receive  dividends  or be deemed the holder of Warrant  Shares or any other
     securities  of the Company that may at any time be issuable on the exercise
     hereof for any purpose, nor shall anything contained herein be construed to
     confer upon the Investor,  as such,  any of the rights of a stockholder  of
     the Company or any right to vote for the  election of directors or upon any
     matter  submitted to  stockholders  at any meeting  thereof,  or to give or
     withhold    consent   to   any   corporate   action   (whether   upon   any
     recapitalization,  issuance of stock,  reclassification of stock, change of
     par  value,  or change  of stock to no par  value,  consolidation,  merger,
     conveyance or otherwise)  or to receive  notice of meetings,  or to receive
     dividends or subscription  rights or otherwise until the Warrant shall have
     been exercised as provided herein.  However, at the time of the exercise of
     this Warrant pursuant to Section 3 hereof,  the Warrant Shares so purchased
     hereunder  shall be deemed to be issued to such holder as the record  owner
     of such  shares  as of the  close of  business  on the  date on which  this
     Warrant shall have been exercised.

8.   Assignment  and Transfer of Warrant.  This Warrant may be assigned in whole
     or in part by the surrender of this Warrant and the Assignment Form annexed
     hereto duly  executed at the office of the Company (or such other office or
     agency of the  Company  as it may  designate  by notice in  writing  to the
     registered  holder  hereof at the address of such holder  appearing  on the
     books of the  Company);  provided,  however,  that this  Warrant may not be
     resold or  otherwise  transferred  except (i) in a  transaction  registered
     under the  Securities  Act of 1933,  as amended (the  "Act"),  or (ii) in a
     transaction pursuant to an exemption, if available, from registration under
     the Act and whereby,  if  requested  by the Company,  an opinion of counsel
     reasonably  satisfactory  to the  Company is obtained by the holder of this
     Warrant to the effect that the transaction is so exempt.

9.   Loss,  Theft,  Destruction  or Mutilation  of Warrant.  Upon receipt by the
     Company  of  evidence  reasonably  satisfactory  to it of the loss,  theft,
     destruction or mutilation of any Warrant or stock certificate  representing
     the Warrant Shares, and in case of loss, theft or destruction, of indemnity
     reasonably satisfactory to it, and upon reimbursement to the Company of all
     reasonable expenses incidental thereto.  Upon surrender and cancellation of
     such Warrant or stock certificate,  if mutilated, the Company will make and
     deliver a new  Warrant or stock  certificate  of like tenor and dated as of
     such cancellation, in lieu of this Warrant or stock certificate.


                                       4


10.  Saturdays,  Sundays,  Holidays,  etc. If the last or appointed  day for the
     taking of any action or the  expiration  of any right  required  or granted
     herein shall be a Saturday, Sunday or a legal holiday, then such action may
     be taken or such right may be  exercised on the next  succeeding  day not a
     legal holiday.

11.  Effect of Certain Events.  If at any time while this Warrant or any portion
     thereof  is  outstanding  and  unexpired  there  shall  be  (i) a  sale  or
     conveyance of all or  substantially  all of the Company's  assets or (ii) a
     transaction  (by merger or  otherwise) in which more than 50% of the voting
     power of the  Company  is  disposed  of  (collectively,  a "Sale or  Merger
     Transaction"),  in which the consideration to be received by the Company or
     its shareholders  consists solely of cash, and in case the Company shall at
     any time effect a Sale or Merger  Transaction in which the consideration to
     be  received  by the  Company  or its  shareholders  consists  in  part  of
     consideration  other than cash,  the holder of this Warrant  shall have the
     right  thereafter  to purchase,  by exercise of this Warrant and payment of
     the aggregate  Exercise Price in effect  immediately  prior to such action,
     the kind and amount of shares and other  securities  and property  which it
     would have owned or have been  entitled to receive  after the  happening of
     such transaction had this Warrant been exercised immediately prior thereto,
     subject to further  adjustment  as provided in Section 12.  Notwithstanding
     the above, a Sale or Merger Transaction shall not be deemed to occur in the
     event the Company is the acquiring entity in connection with an acquisition
     by the Company.

12.  Adjustments of Exercise Price and Number of Warrant Shares.

     The number of and kind of  securities  purchasable  upon  exercise  of this
     Warrant and the Exercise Price shall be subject to adjustment  from time to
     time as follows:

(a)  Subdivisions, Combinations and other Issuances. If the Company shall at any
     time after the date  hereof  but prior to the  expiration  of this  Warrant
     subdivide its outstanding securities as to which purchase rights under this
     Warrant  exist,  by  split-up,  spin-off,  or  otherwise,  or  combine  its
     outstanding  securities  as to which  purchase  rights  under this  Warrant
     exist, the number of Warrant Shares as to which this Warrant is exercisable
     as of the date of such subdivision, split-up, spin-off or combination shall
     forthwith be  proportionately  increased in the case of a  subdivision,  or
     proportionately  decreased  in  the  case  of  a  combination.  Appropriate
     proportional adjustments (decrease in the case of subdivision,  increase in
     the case of  combination)  shall also be made to the Exercise Price payable
     per share,  so that the  aggregate  Exercise  Price  payable  for the total
     number of Warrant  Shares  purchasable  under this  Warrant as of such date
     shall  remain the same as it would have been  before  such  subdivision  or
     combination.

(b)  Stock Dividend. If at any time after the date hereof the Company declares a
     dividend or other  distribution  on Common Stock payable in Common Stock or
     other  securities or rights  convertible  into Common Stock  ("Common Stock
     Equivalents")  without  payment of any  consideration  by holders of Common
     Stock  for the  additional  shares  of  Common  Stock or the  Common  Stock
     Equivalents  (including the additional shares of


                                       5


     Common Stock issuable upon exercise or conversion thereof), then the number
     of shares of Common Stock for which this Warrant may be exercised  shall be
     increased as of the record date (or the date of such dividend  distribution
     if no record date is set) for  determining  which  holders of Common  Stock
     shall be entitled to receive such dividends,  in proportion to the increase
     in the number of  outstanding  shares (and shares of Common Stock  issuable
     upon  conversion of all such securities  convertible  into Common Stock) of
     Common Stock as a result of such dividend,  and the Exercise Price shall be
     proportionately  reduced so that the aggregate  Exercise  Price for all the
     Warrant Shares issuable hereunder  immediately after the record date (or on
     the date of such  distribution,  if  applicable),  for such dividend  shall
     equal the  aggregate  Exercise  Price so payable  immediately  before  such
     record date (or on the date of such distribution, if applicable).

(c)  Other  Distributions.  If at any time  after the date  hereof  the  Company
     distributes  to  holders  of its  Common  Stock,  other than as part of its
     dissolution,  liquidation  or the winding up of its affairs,  any shares of
     its capital stock, any evidence of indebtedness or any of its assets (other
     than  Common  Stock),  then the  number of  Warrant  Shares  for which this
     Warrant  is  exercisable  shall be  increased  to equal:  (i) the number of
     Warrant Shares for which this Warrant is exercisable  immediately  prior to
     such event, (ii) multiplied by a fraction, (A) the numerator of which shall
     be the Fair Market  Value (as defined  below) per share of Common  Stock on
     the record date for the dividend or  distribution,  and (B) the denominator
     of which shall be the Fair Market  Value price per share of Common Stock on
     the record date for the dividend or distribution minus the amount allocable
     to one share of Common  Stock of the value (as jointly  determined  in good
     faith by the Board of Directors  of the Company and the Warrant  holder) of
     any and all such evidences of indebtedness,  shares of capital stock, other
     securities or property, so distributed. For purposes of this Warrant, "Fair
     Market Value" shall equal the 10 Trading Day average  closing trading price
     of the  Common  Stock  on the  Principal  Market  for the 10  Trading  Days
     preceding the date of  determination  or, if the Common Stock is not listed
     or admitted to trading on any Principal Market,  the average of the closing
     bid and asked prices on the over-the-counter market as furnished by any New
     York Stock Exchange  member firm  reasonably  selected from time to time by
     the Company for that purpose and reasonably  acceptable to the Holder,  or,
     if the Common  Stock is not listed or admitted to trading on the  Principal
     Market  or  traded   over-the-counter  and  the  average  price  cannot  be
     determined as contemplated above, the Fair Market Value of the Common Stock
     shall be as reasonably  determined in good faith by the Company's  Board of
     Directors with the  concurrence of the Holder.  The Exercise Price shall be
     reduced to equal: (i) the Exercise Price in effect  immediately  before the
     occurrence of any event (ii) multiplied by a fraction, (A) the numerator of
     which is the number of Warrant Shares for which this Warrant is exercisable
     immediately before the adjustment,  and (B) the denominator of which is the
     number of Warrant Shares for which this Warrant is exercisable  immediately
     after the adjustment.

(d)  Merger,  etc. If at any time after the date hereof  there shall be a merger
     or  consolidation  of the  Company  with or into  or a  transfer  of all or
     substantially all of the assets of the Company to another entity,  then the
     Warrant  Holder shall be entitled to receive  upon or


                                       6


     after such transfer,  merger or consolidation becoming effective,  and upon
     payment of the Exercise Price then in effect, the number of shares or other
     securities  or  property  of the  Company or of the  successor  corporation
     resulting from such merger or consolidation, which would have been received
     by Warrant  Holder for the shares of stock subject to this Warrant had this
     Warrant been exercised just prior to such transfer, merger or consolidation
     becoming  effective or to the applicable  record date thereof,  as the case
     may be. The Company  will not merge or  consolidate  with or into any other
     corporation,  or  sell or  otherwise  transfer  its  property,  assets  and
     business  substantially as an entirety to another  corporation,  unless the
     corporation  resulting  from  such  merger  or  consolidation  (if  not the
     Company),  or such  transferee  corporation,  as the  case  may  be,  shall
     expressly assume in writing the due and punctual performance and observance
     of each and every  covenant  and  condition of this Warrant to be performed
     and observed by the Company.

(e)  Reclassification,  etc. If at any time after the date hereof there shall be
     a reorganization or reclassification of the securities as to which purchase
     rights  under this  Warrant  exist into the same or a  different  number of
     securities  of any other class or classes,  then the Warrant  Holder  shall
     thereafter be entitled to receive upon exercise of this Warrant, during the
     period  specified  herein and upon  payment of the  Exercise  Price then in
     effect, the number of shares or other securities or property resulting from
     such reorganization or reclassification,  which would have been received by
     the Warrant Holder for the shares of stock subject to this Warrant had this
     Warrant at such time been exercised.

(f)  Exercise  Price  Adjustment.  In the event that the Company issues or sells
     any Common Stock or securities  which are convertible  into or exchangeable
     for its Common  Stock or any  convertible  securities,  or any  warrants or
     other  rights  to  subscribe  for or to  purchase  or any  options  for the
     purchase of its Common Stock or any such convertible securities (other than
     shares  or  options  issued  or which  may be  issued  pursuant  to (i) the
     Company's  current or future  employee,  director  or bona fide  consultant
     option plans or shares issued upon exercise of options,  warrants or rights
     outstanding  on the date of the Agreement and listed in the Company's  most
     recent  periodic  report  filed  under  the  Exchange  Act  (ii)  strategic
     corporate  alliances not  undertaken  principally  for financing  purposes,
     (iii)  arrangements  with  the  Investor,  or (iv)  acquisitions  of  other
     entities by the Company) at an effective  Exercise Price per share which is
     less than the Exercise  Price then in effect,  then the  Exercise  Price in
     effect  immediately  prior to such issue or sale shall be reduced effective
     concurrently with such issue or sale to an amount determined by multiplying
     the Exercise Price then in effect by a fraction, (x) the numerator of which
     shall be the sum of (1) the  number of shares of Common  Stock  outstanding
     immediately  prior to such issue or sale,  plus (2) the number of shares of
     Common Stock which the aggregate  consideration received by the Company for
     such  additional  shares  would  purchase  at such  Exercise  Price then in
     effect;  and (y) the  denominator of which shall be the number of shares of
     Common  Stock of the Company  outstanding  immediately  after such issue or
     sale.

     For the purposes of the foregoing  adjustment,  in the case of the issuance
     of any  convertible  securities,  warrants,  options  or  other  rights  to
     subscribe  for or to  purchase  or  exchange  for,  shares of Common  Stock
     ("Convertible  Securities"),  the maximum


                                       7


     number of shares  of Common  Stock  issuable  upon  exercise,  exchange  or
     conversion  of  such   Convertible   Securities   shall  be  deemed  to  be
     outstanding,  provided  that no further  adjustment  shall be made upon the
     actual  issuance of Common Stock upon  exercise,  exchange or conversion of
     such Convertible Securities.

     The number of shares  which may be purchased  hereunder  shall be increased
     proportionately  to any  reduction  in  Exercise  Price  pursuant  to  this
     paragraph  12(f),  so that after such  adjustments  the aggregate  Exercise
     Price payable  hereunder  for the  increased  number of shares shall be the
     same  as the  aggregate  Exercise  Price  in  effect  just  prior  to  such
     adjustments.

13.  Voluntary  Adjustment by the Company. The Company may at its option, at any
     time  during the term of this  Warrant,  reduce but not  increase  the then
     current  Exercise  Price to any amount  and for any  period of time  deemed
     appropriate by the Board of Directors of the Company.

14.  Notice of  Adjustment.  Whenever the number of Warrant  Shares or number or
     kind of securities or other property  purchasable upon the exercise of this
     Warrant or the Exercise Price is adjusted,  the Company shall promptly mail
     to the holder of this Warrant a notice  setting forth the number of Warrant
     Shares (and other securities or property)  purchasable upon the exercise of
     this  Warrant and the  Exercise  Price of such  Warrant  Shares  after such
     adjustment and setting forth a brief  statement of the facts requiring such
     adjustment.

15.  Authorized Shares. The Company covenants that during the period the Warrant
     is  outstanding  and  exercisable,  it will reserve from its authorized and
     unissued  Common  Stock a  sufficient  number of shares to provide  for the
     issuance of the Warrant  Shares upon the  exercise of any  purchase  rights
     under this Warrant. The Company further covenants that its issuance of this
     Warrant  shall  constitute  full  authority to its officers who are charged
     with the duty of  executing  stock  certificates  to execute  and issue the
     necessary  certificates  for the Warrant  Shares  upon the  exercise of the
     purchase  rights  under  this  Warrant.  The  Company  will  take  all such
     reasonable  action as may be necessary  to assure that such Warrant  Shares
     may be issued as provided herein without violation of any applicable law or
     regulation,  or of any  requirements  of the American Stock Exchange or any
     domestic securities exchange upon which the Common Stock may be listed.

16.  9.9% Limitation.

(a)  Notwithstanding  anything to the contrary  contained herein,  the number of
     shares of Common Stock that may be acquired by the Investor  upon  exercise
     pursuant to the terms hereof shall not exceed a number that,  when added to
     the total  number of shares of Common Stock  deemed  beneficially  owned by
     such holder  (other than by virtue of the ownership of securities or rights
     to acquire securities  (including the Warrant) that have limitations on the
     Investor's right to convert, exercise or purchase similar to the limitation
     set  forth  herein),  together  with all  shares  of  Common  Stock  deemed
     beneficially  owned (other than by virtue of the ownership of securities or
     rights to acquire securities


                                       8


     (including  the  Warrant)  that have  limitations  on the right to convert,
     exercise or purchase  similar to the  limitation  set forth  herein) by the
     holder's  "affiliates"  (as  defined  Rule  144 of the  Act)  ("Aggregation
     Parties") that would be aggregated  for purposes of  determining  whether a
     group  under  Section  13(d) of the  Securities  Exchange  Act of 1934,  as
     amended,  exists,  would exceed  9.99% of the total issued and  outstanding
     shares  of  the   Company's   Common  Stock  (the   "Restricted   Ownership
     Percentage").  Each  Holder  shall  have the right (w) at any time and from
     time to time to reduce its Restricted Ownership Percentage immediately upon
     notice  to the  Company  and (x) at any  time and  from  time to  time,  to
     increase its Restricted  Ownership  Percentage  immediately in the event of
     the announcement as pending or planned of an event of:

     (i)  any  consolidation  or  merger of the  Company  with or into any other
          corporation  or other entity or person  (whether or not the Company is
          the surviving corporation),  or any other corporate  reorganization or
          transaction  or series of related  transactions  in which in excess of
          50% of the  Company's  voting power is  transferred  through a merger,
          consolidation, tender offer or similar transaction,

     (ii) any person (as defined in Section 13(d) of the Exchange Act), together
          with its  affiliates and associates (as such terms are defined in Rule
          405  under  the  1933  Act),   beneficially   owns  or  is  deemed  to
          beneficially  own (as  described  in Rule 13d-3 under the Exchange Act
          without regard to the 60-day exercise  period) in excess of 50% of the
          Company's voting power,

     (iii)there is a  replacement  of more than  one-half  of the members of the
          Company's   Board  of  Directors   which  is  not  approved  by  those
          individuals who are members of the Company's Board of Directors on the
          date thereof, in one or a series of related transactions, or

     (iv) a sale or  transfer of all or  substantially  all of the assets of the
          Company, determined on a consolidated basis.

(b)  The  Investor  covenants  at all  times on each day  (each  such day  being
     referred  to as a "Covenant  Day") as  follows:  During the balance of such
     Covenant Day and the  succeeding  sixty-one  (61) days (the balance of such
     Covenant Day and the  succeeding 61 days being referred to as the "Covenant
     Period") such Investor will not acquire  shares of Common Stock pursuant to
     any  right  (including  the  exercise  of  the  Warrant)  existing  at  the
     commencement  of the Covenant  Period to the extent the number of shares so
     acquired  by  such  holder  and  its  Aggregation   Parties  (ignoring  all
     dispositions) would exceed:

     (x)  the Restricted  Ownership  Percentage of the total number of shares of
          Common Stock outstanding at the commencement of the Covenant Period,

     minus

     (y)  the  number of shares of Common  Stock  owned by such  holder  and its
          Aggregation Parties at the commencement of the Covenant Period.


                                       9


          A new and  independent  covenant  will be  deemed  to be  given by the
     holder as of each moment of each Covenant Day. No covenant will  terminate,
     diminish  or modify any other  covenant.  The holder  agrees to comply with
     each such  covenant.  This  Section 16 controls in the case of any conflict
     with any other provision of the Transaction Documents.

          The  Company's  obligation to issue shares of Common Stock which would
     exceed such limits referred to in this Section 16 shall be suspended to the
     extent  necessary until such time, if any, as shares of Common Stock may be
     issued in compliance with such restrictions.

17.  Compliance with Securities Laws.

(a)  The holder hereof  acknowledges  that the Warrant Shares  acquired upon the
     exercise  of this  Warrant,  if not  registered  (or if no  exemption  from
     registration  exists),  will have restrictions upon resale imposed by state
     and federal  securities  laws. Each  certificate  representing  the Warrant
     Shares  issued to the Holder  upon  exercise  (if not  registered  or if no
     exemption from registration exists) will bear the following legend:

     THE SHARES  REPRESENTED BY THIS  CERTIFICATE  HAVE NOT BEEN REGISTERED WITH
     THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES  COMMISSION OF ANY
     STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION  UNDER THE SECURITIES
     ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"), AND,  ACCORDINGLY,  MAY NOT
     BE OFFERED,  TRANSFERRED,  SOLD OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO
     AN EFFECTIVE REGISTRATION STATEMENT UNDER THE SECURITIES ACT OR PURSUANT TO
     AN  AVAILABLE  EXEMPTION  FROM,  OR IN A  TRANSACTION  NOT  SUBJECT TO, THE
     REGISTRATION  REQUIREMENTS  OF THE  SECURITIES  ACT AND IN ACCORDANCE  WITH
     APPLICABLE  STATE  SECURITIES  LAWS,  BASED ON AN OPINION LETTER OF COUNSEL
     SATISFACTORY  TO THE COMPANY OR A NO-ACTION  LETTER FROM THE SECURITIES AND
     EXCHANGE COMMISSION.

(b)  Without  limiting the  Investor's  right to  transfer,  assign or otherwise
     convey the  Warrant or Warrant  Shares in  compliance  with all  applicable
     securities  laws,  the  Investor of this  Warrant,  by  acceptance  hereof,
     acknowledges  that this  Warrant and the  Warrant  Shares to be issued upon
     exercise  hereof are being  acquired  solely for the Investor's own account
     and not as a nominee for any other party,  and that the  Investor  will not
     offer,  sell or otherwise  dispose of this Warrant or any Warrant Shares to
     be issued upon  exercise  hereof except under  circumstances  that will not
     result in a violation of applicable federal and state securities laws. Upon
     exercise of this Warrant,  the Investor shall, if requested by the Company,
     confirm in writing, in a form satisfactory to the Company, that the Warrant
     Shares of Common  Stock so  purchased  are being  acquired  solely  for the


                                       10


     Investor's  own  account  and not as a  nominee  for any other  party,  for
     investment, and not with a view toward distribution or resale.

(c)  Neither this Warrant nor any Share of Common Stock issued upon  exercise of
     this Warrant may be offered for sale or sold, or otherwise  transferred  or
     sold in any  transaction  which would  constitute a sale thereof within the
     meaning of the Act,  unless (i) such security has been  registered for sale
     under the Act and registered or qualified under applicable state securities
     laws relating to the offer an sale of securities,  or (ii)  exemptions from
     the   registration   requirements  of  the  Act  and  the  registration  or
     qualification  requirements of all such state securities laws are available
     and the Company shall have received an opinion of counsel that the proposed
     sale or  other  disposition  of such  securities  may be  effected  without
     registration   under  the  Act,   such  counsel  and  such  opinion  to  be
     satisfactory to the Company.

(d)  Investor  recognizes  that  investing in the Warrant and the Warrant Shares
     involves a high degree of risk, and Investor is in a financial  position to
     hold the Warrant and the Warrant  Shares  indefinitely  and is able to bear
     the economic risk and  withstand a complete  loss of its  investment in the
     Warrant and the Warrant Shares.  The Investor is a  sophisticated  investor
     and is capable of  evaluating  the  merits  and risks of  investing  in the
     Company.  The  Investor  has had an  opportunity  to discuss the  Company's
     business,  management and financial affairs with the Company's  management,
     has been given  full and  complete  access to  information  concerning  the
     Company,  and has utilized such access to its  satisfaction for the purpose
     of  obtaining  information  or  verifying  information  and  have  had  the
     opportunity  to  inspect  the  Company's  operation.  Investor  has had the
     opportunity  to ask questions of, and receive  answers from, the management
     of the Company (and any person acting on its behalf) concerning the Warrant
     and the Warrant  Shares and the agreements  and  transactions  contemplated
     hereby,  and to obtain any  additional  information  as  Investor  may have
     requested in making its investment  decision.  The initial Investor in this
     Warrant is an "accredited investor", as defined by Regulation D promulgated
     under the Act.

18.  Miscellaneous.

(a)  Issue Date;  Choice Of Law;  Venue;  Jurisdiction.  THE  PROVISIONS OF THIS
     WARRANT  SHALL BE CONSTRUED AND SHALL BE GIVEN EFFECT IN ALL RESPECTS AS IF
     IT HAD BEEN ISSUED AND  DELIVERED BY THE COMPANY ON THE DATE  HEREOF.  THIS
     WARRANT  SHALL BE BINDING  UPON ANY  SUCCESSORS  OR ASSIGNS OF THE COMPANY.
     THIS WARRANT WILL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH AND GOVERNED
     BY THE LAWS OF THE STATE OF NEW YORK,  EXCEPT FOR MATTERS ARISING UNDER THE
     ACT,  WITHOUT  REFERENCE TO  PRINCIPLES  OF  CONFLICTS OF LAW.  EACH OF THE
     PARTIES CONSENTS TO THE EXCLUSIVE  JURISDICTION OF THE U.S.  DISTRICT COURT
     SITTING  IN THE  STATE  OF CITY OF NEW  YORK IN THE  STATE  OF NEW  YORK IN
     CONNECTION  WITH ANY DISPUTE  ARISING UNDER THIS WARRANT AND HEREBY WAIVES,
     TO THE MAXIMUM


                                       11


     EXTENT  PERMITTED BY LAW, ANY OBJECTION,  INCLUDING ANY OBJECTION  BASED ON
     FORUM  NON  CONVENIENS,  TO THE  BRINGING  OF ANY SUCH  PROCEEDING  IN SUCH
     JURISDICTION.  EACH PARTY  HEREBY  AGREES  THAT IF THE OTHER  PARTY TO THIS
     WARRANT OBTAINS A JUDGMENT AGAINST IT IN SUCH A PROCEEDING, THE PARTY WHICH
     OBTAINED SUCH  JUDGMENT MAY ENFORCE SAME BY SUMMARY  JUDGMENT IN THE COURTS
     OF ANY  COUNTRY  HAVING  JURISDICTION  OVER THE  PARTY  AGAINST  WHOM  SUCH
     JUDGMENT WAS OBTAINED,  AND EACH PARTY HEREBY WAIVES ANY DEFENSES AVAILABLE
     TO IT UNDER  LOCAL LAW AND AGREES TO THE  ENFORCEMENT  OF SUCH A  JUDGMENT.
     EACH PARTY TO THIS WARRANT  IRREVOCABLY  CONSENTS TO THE SERVICE OF PROCESS
     IN ANY SUCH  PROCEEDING  BY THE MAILING OF COPIES  THEREOF BY REGISTERED OR
     CERTIFIED MAIL, POSTAGE PREPAID, TO SUCH PARTY AT ITS ADDRESS IN ACCORDANCE
     WITH SECTION  18(C).  NOTHING HEREIN SHALL AFFECT THE RIGHT OF ANY PARTY TO
     SERVE  PROCESS IN ANY OTHER MANNER  PERMITTED BY LAW. EACH PARTY WAIVES ITS
     RIGHT TO A TRIAL BY JURY.

(b)  Modification  and Waiver.  This  Warrant and any  provisions  hereof may be
     changed, waived,  discharged or terminated only by an instrument in writing
     signed by the party against which  enforcement  of the same is sought.  Any
     amendment  effected in accordance with this paragraph shall be binding upon
     the  Investor,  each  future  holder of this  Warrant and the  Company.  No
     waivers of, or  exceptions  to, any term,  condition  or  provision of this
     Warrant, in any one or more instances,  shall be deemed to be, or construed
     as,  a  further  or  continuing  waiver  of any  such  term,  condition  or
     provision.

(c)  Notices. Any notice,  request or other document required or permitted to be
     given or delivered to the Investor or future  holders hereof or the Company
     shall be  personally  delivered or shall be sent by certified or registered
     mail,  postage prepaid,  to the Investor or each such holder at its address
     as shown on the books of the  Company or to the  Company at the address set
     forth in the  Agreement.  All notices under this Warrant shall be deemed to
     have been given when received.

     A party may from time to time change the address to which notices to it are
     to be  delivered  or mailed  hereunder  by notice  in  accordance  with the
     provisions of this Section 18(c).

(d)  Severability.  Whenever  possible,  each provision of this Warrant shall be
     interpreted  in such manner as to be effective  and valid under  applicable
     law, but if any provision of this Warrant is held to be invalid, illegal or
     unenforceable  in any  respect  under  any  applicable  law or  rule in any
     jurisdiction,  such invalidity,  illegality or  unenforceability  shall not
     affect the validity,  legality or  enforceability of any other provision of
     this  Warrant in such  jurisdiction  or affect the  validity,  legality  or
     enforceability of any provision in any other jurisdiction, but this Warrant
     shall be reformed,  construed and enforced in such


                                       12


     jurisdiction  as if such invalid,  illegal or  unenforceable  provision had
     never been contained herein.

(e)  No  Impairment.  The Company will not, by amendment of its  Certificate  of
     Incorporation   or  through   any   reorganization,   transfer  of  assets,
     consolidation,  merger,  dissolution,  issue or sale of  securities  or any
     other  voluntary  action,   avoid  or  seek  to  avoid  the  observance  or
     performance  of any of the terms of this Warrant,  but will at all times in
     good faith  assist in the  carrying out of all such terms and in the taking
     of all such action as may be necessary or  appropriate  in order to protect
     the rights of the Warrant Holder against  impairment.  Without limiting the
     generality  of the  foregoing,  the Company (a) will not  increase  the par
     value of any  Warrant  Shares  above the amount  payable  therefor  on such
     exercise,  and (b) will take all such action as may be reasonably necessary
     or  appropriate  in order that the Company  may  validly and legally  issue
     fully  paid  and  nonassessable  Warrant  Shares  on the  exercise  of this
     Warrant.


                                       13


     IN WITNESS  WHEREOF,  the Company has caused this Warrant to be executed by
its officers thereunto duly authorized.

Dated: September 1, 2000

                                             PHARMOS CORPORATION


                                             By:
                                                --------------------------------
                                                Name:
                                                Title:
Agreed and Accepted
this 1st day of September, 2000

[____________________}


By:
    -------------------------------
    Name:
    Title:



                                       14


                               NOTICE OF EXERCISE


To:  PHARMOS CORPORATION

(1)  The undersigned hereby elects:

     (A) to  purchase  ________  shares of Common  Stock of Pharmos  Corporation
pursuant to the terms of the attached  Warrant,  and tenders herewith payment of
the Exercise Price in full, together with all applicable transfer taxes, if any.

     (B)  in  a  "cashless"  or  "net-issue   exercise"  for,  and  to  purchase
thereunder,  ______ shares of Common Stock,  and herewith makes payment therefor
with _______ Surrendered Shares.

(2) Please  issue a  certificate  or  certificates  representing  said shares of
Common  Stock  in the  name  of the  undersigned  or in  such  other  name as is
specified below:

                           -------------------------------
                           (Name)

                           -------------------------------
                           (Address)
                           -------------------------------

(3) Please  issue a new  Warrant  for the  unexercised  portion of the  attached
Warrant in the name of the  undersigned  or in such  other name as is  specified
below:

                           Other Name: ___________________


                                     ------------------------------------------
                                     (Name)


- ---------------------------          ------------------------------------------
(Date)                               (Signature)


                                     ------------------------------------------
                                     (Address)




                                 ASSIGNMENT FORM

                    (To assign the foregoing warrant, execute
                   this form and supply required information.
                 Do not use this form to exercise the warrant.)


     FOR VALUE RECEIVED,  the foregoing  Warrant of Pharmos  Corporation and all
rights evidenced thereby are hereby assigned to

_______________________________________________ whose address is

____________________________________________________________________________.




____________________________________________________________________________.


                                                       Dated: ______________,


                           Holder's Signature: ______________________________

                           Holder's Address:   ______________________________

                                               ______________________________



Signature Guaranteed:  ___________________________________________




NOTE: The signature to this  Assignment Form must correspond with the name as it
appears on the face of the Warrant,  without  alteration or  enlargement  or any
change whatsoever,  and must be guaranteed by a bank or trust company.  Officers
of  corporations  and  those  acting  in an  fiduciary  or other  representative
capacity  should  file  proper  evidence of  authority  to assign the  foregoing
Warrant.